Lobbying client
PPLA
Pharmaceutical Literature
Filings
36
Filed by
1
Reported in-house
—
Reported by firms
$630,150
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2018 to 2026
Filings
4 filings for 2023, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2023
|
JACOBS & ASSOCIATES, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | $18,700 reported |
|
3rd Quarter - Report 3rd Quarter 2023
|
JACOBS & ASSOCIATES, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | $18,700 reported |
|
2nd Quarter - Report 2nd Quarter 2023
|
JACOBS & ASSOCIATES, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | $18,700 reported |
|
1st Quarter - Report 1st Quarter 2023
|
JACOBS & ASSOCIATES, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | $18,700 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| JACOBS & ASSOCIATES, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 33 | $630,150 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 30 |
| Pharmacy | PHA | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.